Evidence map›Paper›PMID 31439299›Full record

SynthesisJACC. Clinical electrophysiology2019

Meta-Analysis of Randomized Controlled Trials of Atrial Fibrillation Ablation With Pulmonary Vein Isolation Versus Without.

Arunashis Sau, James P Howard, Sayed Al-Aidarous, João Ferreira-Martins, Becker Al-Khayatt, P Boon Lim, Prapa Kanagaratnam, Zachary I Whinnett, Nicholas S Peters, Markus B Sikkel and 2 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in JACC. Clinical electrophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prospective validation of SURPOINT index for creating atrial scar using Magnetic Resonance Imaging.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Comparison of voltages between atria: differences in sinus rhythm and atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  15. Article
  16. Emerging Tools and Techniques for Catheter Ablation of Cardiac Arrhythmias: A 2024 Update.The Journal of innovations in cardiac rhythm management · 2024
    Article
  17. Article
  18. Review
  19. Comparing the efficacy of catheter ablation strategies for persistent atrial fibrillation: a Bayesian analysis of randomized controlled trials.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Arunashis SauNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
James P HowardNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
Sayed Al-AidarousNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
João Ferreira-MartinsNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Becker Al-KhayattNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
P Boon LimNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
Prapa KanagaratnamNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
Zachary I WhinnettNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
Nicholas S PetersNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
Markus B SikkelNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Royal Jubilee Hospital, Victoria, Canada.
Darrel P FrancisNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
S M Afzal SohaibNational Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiac Electrophysiology, Bart's Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Department of Cardiology, King George Hospital, Ilford, United Kingdom. Electronic address: a.sohaib@nhs.net.
Imperial College London · GBImperial College Healthcare NHS Trust · GBHammersmith Hospital · GBRoyal Brompton & Harefield NHS Foundation Trust · GB

Funding

British Heart Foundation FS 04/079British Heart Foundation FS/13/44/30291Department of HealthWellcome TrustWellcome Trust 212183/Z/18/Z
6 · The paper itself

Abstract

objectivesThis meta-analysis examined the ability of pulmonary vein isolation (PVI) to prevent atrial fibrillation in randomized controlled trials (RCTs) in which the patients not receiving PVI nevertheless underwent a procedure.

backgroundPVI is a commonly used procedure for the treatment of atrial fibrillation (AF), and its efficacy has usually been judged against therapy with anti-arrhythmic drugs in open-label trials. There have been several RCTs of AF ablation in which both arms received an ablation, but the difference between the treatment arms was inclusion or omission of PVI. These trials of an ablation strategy with PVI versus an ablation strategy without PVI may provide a more rigorous method for evaluating the efficacy of PVI.

methodsMedline and Cochrane databases were searched for RCTs comparing ablation including PVI with ablation excluding PVI. The primary efficacy endpoint was freedom from atrial fibrillation (AF) and atrial tachycardia at 12 months. A random-effects meta-analysis was performed using the restricted maximum likelihood estimator.

resultsOverall, 6 studies (n = 610) met inclusion criteria. AF recurrence was significantly lower with an ablation including PVI than an ablation without PVI (RR: 0.54; 95% confidence interval [CI]: 0.33 to 0.89; p = 0.0147; I

conclusionsIn RCTs where both arms received an ablation, and therefore an expectation amongst patients and doctors of benefit, being randomized to PVI had a striking effect, reducing AF recurrence by a half.

Indexed as

Catheter AblationAtrial FibrillationFemaleHumansMaleMiddle AgedPulmonary VeinsRandomized Controlled Trials as TopicRecurrenceablationatrial fibrillationpulmonary vein isolation

Identifiers

PMID31439299
PMCPMC6709782
OpenAlexW2966220467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.